Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.430
-0.080 (-5.30%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $102.69 million as of April 25, 2025. Its market cap has decreased by -90.81% in one year.
Market Cap
102.69M
Enterprise Value
-225.39M
1-Year Change
-90.81%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $129.95M to $102.69M, a decrease of -20.98%. That is a compound annual growth rate of -4.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 108.44M | -49.78% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | 2.11B | 1,523.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.39B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |